191 related articles for article (PubMed ID: 31696619)
21. A Biodegradable Polyethylenimine-Based Vector Modified by Trifunctional Peptide R18 for Enhancing Gene Transfection Efficiency In Vivo.
Hu J; Zhu M; Liu K; Fan H; Zhao W; Mao Y; Zhang Y
PLoS One; 2016; 11(12):e0166673. PubMed ID: 27935984
[TBL] [Abstract][Full Text] [Related]
22. Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid.
Layek B; Lipp L; Singh J
Int J Mol Sci; 2015 Dec; 16(12):28912-30. PubMed ID: 26690119
[TBL] [Abstract][Full Text] [Related]
23. Enhanced gene transfection efficiency by use of peptide vectors containing laminin receptor-targeting sequence YIGSR.
Meng Z; Kang Z; Sun C; Yang S; Zhao B; Feng S; Meng Q; Liu K
Nanoscale; 2018 Jan; 10(3):1215-1227. PubMed ID: 29292451
[TBL] [Abstract][Full Text] [Related]
24. pH-responsive three-layered PEGylated polyplex micelle based on a lactosylated ABC triblock copolymer as a targetable and endosome-disruptive nonviral gene vector.
Oishi M; Kataoka K; Nagasaki Y
Bioconjug Chem; 2006; 17(3):677-88. PubMed ID: 16704205
[TBL] [Abstract][Full Text] [Related]
25. A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy.
Duguid JG; Li C; Shi M; Logan MJ; Alila H; Rolland A; Tomlinson E; Sparrow JT; Smith LC
Biophys J; 1998 Jun; 74(6):2802-14. PubMed ID: 9635734
[TBL] [Abstract][Full Text] [Related]
26. Characters of dendritic poly(L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro.
Okuda T; Sugiyama A; Niidome T; Aoyagi H
Biomaterials; 2004 Feb; 25(3):537-44. PubMed ID: 14585703
[TBL] [Abstract][Full Text] [Related]
27. Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification.
Agirre M; Zarate J; Puras G; Ojeda E; Pedraz JL
Drug Deliv; 2015 Jan; 22(1):100-10. PubMed ID: 24471693
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides.
Moore NM; Sheppard CL; Sakiyama-Elbert SE
Acta Biomater; 2009 Mar; 5(3):854-64. PubMed ID: 18926782
[TBL] [Abstract][Full Text] [Related]
29. Development of a Targeted anti-HER2 scFv Chimeric Peptide for Gene Delivery into HER2-Positive Breast Cancer Cells.
Cheraghi R; Nazari M; Alipour M; Majidi A; Hosseinkhani S
Int J Pharm; 2016 Dec; 515(1-2):632-643. PubMed ID: 27825868
[TBL] [Abstract][Full Text] [Related]
30. Emerging vectors and targeting methods for nonviral gene therapy.
Lavigne MD; Górecki DC
Expert Opin Emerg Drugs; 2006 Sep; 11(3):541-57. PubMed ID: 16939390
[TBL] [Abstract][Full Text] [Related]
31. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo.
Rittner K; Benavente A; Bompard-Sorlet A; Heitz F; Divita G; Brasseur R; Jacobs E
Mol Ther; 2002 Feb; 5(2):104-14. PubMed ID: 11829517
[TBL] [Abstract][Full Text] [Related]
32. In vitro investigation of factors important for the delivery of an integrin-targeted nonviral DNA vector in organ transplantation.
Collins L; Sawyer GJ; Zhang XH; Gustafsson K; Fabre JW
Transplantation; 2000 Mar; 69(6):1168-76. PubMed ID: 10762223
[TBL] [Abstract][Full Text] [Related]
33. An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection.
Lo SL; Wang S
Biomaterials; 2008 May; 29(15):2408-14. PubMed ID: 18295328
[TBL] [Abstract][Full Text] [Related]
34. Development of a receptor-targeted gene delivery system using CXCR4 ligand-conjugated cross-linking peptides.
Egorova A; Bogacheva M; Shubina A; Baranov V; Kiselev A
J Gene Med; 2014; 16(11-12):336-51. PubMed ID: 25382058
[TBL] [Abstract][Full Text] [Related]
35. Avidin-biotin interaction mediated peptide assemblies as efficient gene delivery vectors for cancer therapy.
Qu W; Chen WH; Kuang Y; Zeng X; Cheng SX; Zhou X; Zhuo RX; Zhang XZ
Mol Pharm; 2013 Jan; 10(1):261-9. PubMed ID: 23146022
[TBL] [Abstract][Full Text] [Related]
36. Peptide vector for gene delivery with high affinity for phosphatidylserine.
Kuriyama S; Taguchi Y; Nishimura K; Mizuguchi K; Kobayashi K; Katayama Y; Yanagibashi K; Niidome T
J Pept Sci; 2006 Oct; 12(10):626-32. PubMed ID: 16710871
[TBL] [Abstract][Full Text] [Related]
37. Cationic star polymers consisting of alpha-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors.
Yang C; Li H; Goh SH; Li J
Biomaterials; 2007 Jul; 28(21):3245-54. PubMed ID: 17466370
[TBL] [Abstract][Full Text] [Related]
38. Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery.
Arsianti M; Lim M; Marquis CP; Amal R
Langmuir; 2010 May; 26(10):7314-26. PubMed ID: 20112951
[TBL] [Abstract][Full Text] [Related]
39. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery.
Bremner KH; Seymour LW; Logan A; Read ML
Bioconjug Chem; 2004; 15(1):152-61. PubMed ID: 14733595
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy vectors with enhanced transfection based on hydrogels modified with affinity peptides.
Shepard JA; Wesson PJ; Wang CE; Stevans AC; Holland SJ; Shikanov A; Grzybowski BA; Shea LD
Biomaterials; 2011 Aug; 32(22):5092-9. PubMed ID: 21514659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
